1. Kessler RC, Berglund PA, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R) Arch Gen Psychiatry. 2005;62:593–602. [PubMed] 2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidty Survey Replication. Arch Gen Psychiatry. 2005;62:617–627. [PMC free article] [PubMed]
3. Beck AT, Emery G. Anxiety disorders and phobias: A cognitive perspective. 15th annual edition. New York: Basic Books; 2005.
4. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006;26:17–31. [PubMed] 5. Chalmers TC. Problems induced by meta-analyses. Stat Med. 1991;10:971–980. [PubMed]
6. Hunter JE, Schmidt FL. Methods of meta-analysis. Newbury Park, CA: Sage; 1990.
7. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282:1054–1060. [PubMed] 8. Klein DF. Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry. 2000;157:1204–1211. [PubMed] 9. Moher D, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Claussen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–613. [PubMed] 10. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in randomized controlled clinical trials. JAMA. 1995;273:408–412. [PubMed] 11. Lavori PW. Placebo control groups in randomized treatment trials: A statistician’s perspective. Biol Psychiatry. 2000;47:717–723. [PubMed] 12. Weisz JR, Jensen-Doss A, Hawley KM. Evidence-based youth psychotherapies versus usual clinical care: A meta-analysis of direct comparisons. Am Psychol. 2006;61:671–689. [PubMed]
13. Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press; 1985.
14. Miettinen OS, Nurminen M. Comparative analysis of two rates. Stat. Med. 1985;4:213–226. [PubMed]
15. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998;3:486–504.
16. DerSimonian R, Laird NM. Meta-analysis in Clinical Trials. Control Clin Trials. 1986;7:177–178. [PubMed]
17. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull. 1979;86:638–641.
18. Cooper H, Hedges LV. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. pp. 261–281.
19. Rosenthal R. Meta-analytic procedures for social research. rev. ed. Thousand Oaks, CA: Sage Publications, Inc; 1991.
20. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis, version 2. Englewood, New Jersey: Biostat Inc; 2005.
21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control. Clin.Trials. 1996;17:1–12. [PubMed] 22. Bryant RA, Harvey AG, Dang ST, Sackville T, Basten C. Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol. 1998;66:862–866. [PubMed] 23. Horowitz MJ, Wilner N, Alvarez W. Impact of event scale: A measure of subjective stress. Psychosom Med. 1979;41:209–218. [PubMed]
24. Beck AT, Steer RA, Brown GK. Beck Depression Inventory, Manual. 2nd ed. San Antonio, Tex: Psychological Corp; 1996.
25. Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R. Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychiatry. 1999;156:1780–1786. [PubMed] 26. Bryant RA, Moulds ML, Nixon RVD. Cognitive behaviour therapy of acute stress disorder: A four-year follow-up. Behav Res Ther. 2003;41:489–494. [PubMed] 27. Bryant RA, Moulds ML, Guthrie RM, Nixon RDV. The additive benefit of hypnosis and cognitive-behavioral therapy in treating acute stress disorder. J Consult Clin Psychol. 2005;73:334–340. [PubMed] 28. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1993;61:611–619. [PubMed] 29. Hamilton M. The measurement of anxiety states by rating. Br J Med Psychol. 1959;32:50–55. [PubMed]
30. DiNardo PA, Barlow DH. Anxiety Disorder Interview Schedule-Revised (ADIS-R) Albany, NY: Phobia and Anxiety Disorders Clinic, State University of New York; 1988.
31. Hamilton M. A rating scale for depression. J Neurol Neurosurgery Psychiatry. 1960;23:56–62.
32. Spielberger CD, Gorsuch RL, Lushene RE. State-Trait Anxiety Inventory, Manual. Palo Alto, CA: Consulting Psychologists Press; 1970.
33. Zung WWK. A rating instrument for anxiety disorders. Psychosom. 1975;12:371–379.
34. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28:487–495. [PubMed] 35. Wetherell JL, Gatz M, Craske MG. Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol. 2003;71:31–40. [PubMed]
36. DiNardo PA, Brown TA, Barlow DH. Anxiety Disorders Interview Schedule for DSM-IV. Boston, MA: Center for Anxiety and Related Disorders at Boston University; 1994.
37. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893–897. [PubMed] 38. Foa EB, Liebowitz MR, Kozak MJ, Davies S. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162:151–161. [PubMed]
39. Guy W. ECDEU assessment manual for psychopharmacology: publication ADM 76-338. Washington (DC): US Department of Health, Education and Welfare; 1976. pp. 217–222.
40. Goodman WK, Price LH, Rasmussen SA, Mazure, Fleischmann RL, Hill CR, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011. [PubMed] 41. Greist JH, Marks IM, Baer L, Kobak KA. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry. 2002;63:138–145. [PubMed]
42. Marks I. Behavioral Psychotherapy. Bristol, England: John Wright; 1986. p. 46.
43. Sanavio E. Obsessions and compulsions: The Padua Inventory. Behav Res Ther. 1988;26:169–177. [PubMed] 44. Hodgson RJ, Rachman S. Obsessive compulsive complaints. Behav Res Ther. 1977;15:389–395. [PubMed] 45. Lindsay M, Crino R, Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry. 1997;171:135–139. [PubMed] 46. Bakker A, van Dyck R, Spinhoven P, van Balkom AJLM. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry. 1999;60:831–838. [PubMed]
47. Sheehan DV. The anxiety disease. New York, NY: Charles Scribner’s Sons; 1983. pp. 144–153.
48. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389. [PubMed] 49. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000;283:2529–2536. [PubMed] 50. Shear MK, Brown TA, Barlow DH, Money R, Gorman JM, Woods SW. Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry. 1997;154:1571–1575. [PubMed] 51. Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry. 1993;50:44–50. [PubMed] 52. Snaith RP, Baugh SJ, Clayden AD, Husain A, Supple MA. The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry. 1982;141:518–523. [PubMed] 53. Craske MG, Maidenberg E, Bystritsky A. Brief cognitive-behavioral versus nondirective therapy for panic disorder. J Behav Ther Exp Psychiatry. 1995;26:113–120. [PubMed] 54. Reiss A, Peterson R, Gursky D, McNally R. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behav Res Ther. 1986;24:1–8. [PubMed] 55. Marks I, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther. 1979;17:263–267. [PubMed]
56. Bystritsky A. Development of a multidimensional scale of anxiety. J Anxiety Dis. 1990;4:99–115.
57. Sharp DM, Power KG, Simpson RJ, Swanson C. Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord. 1996;10:219–242.
58. Blanchard EB, Hickling EJ, Devineni T, Veazey CH, Galovski TE, Mundy E, Malta LS, Buckley TC. A controlled evaluation of cognitive behavioral therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003;41:79–96. [PubMed] 59. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician administered PTSD scale. J Trauma Stress. 1995;8:75–90. [PubMed] 60. Derogatis LR, Melisaratos N. The brief symptom inventory: An introductory report. Psychol Med. 1983;13:595–605. [PubMed] 61. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, Mcdonal-Scott P, Andreasen NC. A longitudinal interval follow-up evaluation: A comprehensive method for assessing outcome and prospective longitudinal studies. Arch Gen Psychiatry. 1987;44:540–548. [PubMed]
62. Weathers FW, Litz B, Huska JA, Keane TM. PCL-C for DSM-IV (PTSD Checklist) Boston, MA: National Center for Posttraumatic Stress Disorder; 1995.
63. Bryant RA, Moulds ML, Guthrie RM, Dang ST, Nixon RD. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003;71:706–712. [PubMed]
64. Khawaja NG, Oei TP. Development of a catastrophic cognition questionnaire. J Anxiety Dis. 1992;6:305–318.
65. Foa EB, Rothbaum BO, Riggs DS, Murdock TB. Treatment of posttraumatic stress disorder in rape victims: A comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991;59:715–723. [PubMed]
66. Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 1993;6:459–473.
67. Marks IM, Lovell K, Noshirvani H, Livanou M, Thrasher S. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring. Arch Gen Psychiatry. 1998;55:317–325. [PubMed] 68. McDonagh A, Friedman M, McHugo G, Ford J, Sengupta A, Mueser K, Demment CC, Fournier D, Schnurr PP, Descamps M. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005;73:515–524. [PubMed]
69. Frisch MB, Cornell J, Villanueva M, Retzlaff PJ. Clinical validation of the Quality of Life Inventory: A measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assessment. 1992;4:92–101.
70. Neuner F, Schauer M, Klaschik C. A comparison of narrative exposure therapy, supportive counseling, and psychoeducation for treating posttraumatic stress disorder in an African refugee settlement. J Consult Clin Psychol. 2004;72:579–587. [PubMed]
71. Foa EB. Post-traumatic Stress Diagnostic Scale (PDS) Minneapolis, MS: National Computer Systems; 1995.
72. Kellner R, Sheffield BF. A self-rating scale of distress. Psychol Med. 1973;3:88–100. [PubMed] 73. Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B. Cognitive therapy versus fluoxetine in generalized social phobia: A randomized placebo-controlled trial. J Consult Clin Psychol. 2003;71:1058–1067. [PubMed] 74. Mattick RP, Clarke JC. Development and validation of measures of social scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36:455–470. [PubMed] 75. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–173. [PubMed] 76. Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969;33:448–457. [PubMed] 77. Cottraux J, Note I, Albuisson E, Yao SN, Note B, Mollard E, Bonasse F, Jalenques I, Guérin J, Coudert AJ. Cognitive behavior therapy versus supportive therapy in social phobia: A randomized controlled trial. Psychother Psychosom. 2000;69:137–146. [PubMed]
78. Glass CR, Merluzzi T, Biever JL, Larsen K. Cognitive assessment of social anxiety: development and validation of a self-statement questionnaire. Cogn Ther Res. 1982;6:37–55.
79. Davidson JRT, Foa EB, Huppert JD, Keefe FJ, Franklin MW, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004;61:1005–1013. [PubMed] 80. Davidson JRT, Miner CM, de Veaugh Geiss J, Tupler LA, Colket JT, Potts NLS. The Brief Social Phobia Scale: A psychometric evaluation. Psychol Med. 1997;27:161–166. [PubMed]
81. Turner SM, Beidel DC, Dancu CV, Stanley MA. An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory. J Consult Clin Psychol. 1989;1:35–40.
82. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry. 1998;55:1133–1141. [PubMed] 83. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman JM, Papp L, Davies S, Gully R, Klein DF. Phenelzine vs. atenolol in social phobia: A placebo-controlled comparison. Arch Gen Psychiatry. 1992;49:290–300. [PubMed]
84. Derogatis LR. SCL-90 Administration, Scoring, and Procedures Manual for the Revised Version. Baltimore, Md: John Hopkins University Press; 1977.
85. Lucas RA. A comparative treatment outcome study of social phobia. Diss Abstr. 1994;54:6465.
86. Smits JA, Rosenfield D, McDonald R, Telch MJ. Cognitive mechanisms of social anxiety reduction: an examination of specificity and temporality. Behav Res Ther. 2006;74:1203–1212.
87. Baker SL, Heinrichs N, Kim HJ, Hofmann SG. The Liebowitz Social Anxiety Scale as a self-report instrument: A preliminary psychometric analysis. Behav Res Ther. 2002;40:701–715. [PubMed] 88. Turner SM, Beidel DC, Jacob RG. Social phobia: A comparison of behavior therapy and atenolol. J Consult Clin Psychol. 1994;62:350–358. [PubMed] 89. Abramowitz JS. Effectiveness of psychological and pharmacological treatment for obsessive-compulsive disorder: A quantitative review. J Consult Clin Psychol. 1997;65:44–52. [PubMed] 90. Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S. Psychological treatment for chronic post-traumatic stress disorder. Systematic review and meta-analysis. Br J Psychiatry. 2007;190:97–104. [PubMed]
91. Gould RA, Buckminster S, Pollack MH, Otto MW, Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clin Psychol (New York) 1997;4:291–306.
92. Mitte K. Meta-analysis of cognitive-behavioral treatment for generalized anxiety disorder: A comparison with pharmacotherapy. Psychol Bull. 2005;131:785–795. [PubMed] 93. Mitte K. A meta-analysis of the efficacy of psych- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005;88:27–45. [PubMed] 94. Baskin TW, Tierney SC, Minami T, Wampold BE. Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls. J Consult Clin Psychol. 2003;71:973–979. [PubMed] 95. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63:298–304. [PubMed] 96. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61:1136–1144. [PubMed] 97. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12–19. [PubMed]